Hostname: page-component-cb9f654ff-d5ftd Total loading time: 0 Render date: 2025-08-31T05:37:19.637Z Has data issue: false hasContentIssue false
  • English
  • Français

A Double-Blind Out-Patient Trial of Indalpine vs Mianserin

Published online by Cambridge University Press:  29 January 2018

G. J. Naylor  and
B. Martin
G. J. Naylor*
Affiliation:
The Department of Psychiatry University of Dundee, Dundee DD1 9SY, Scotland
B. Martin
Affiliation:
Royal Dundee Liff Hospital, Dundee DD2 5NF, Scotland
*
∗ Correspondence
Get access Rights & Permissions [Opens in a new window]

Summary

Indalpine 150 mg per day and mianserin 60 mg per day were compared in a double-blind study of 65 depressed out-patients: 52 patients completed the 4-week trial. At the end of four weeks there was no significant difference in antidepressant effect between the two drugs; but in the first two weeks, improvement in the mianserin-treated group was significantly greater than that in the indalpine group. The mianserin-treated group reported more side-effects of sedation (eg. drowsiness, clumsiness, heaviness of limbs etc.) and one patient on indalpine developed a mild leucopenia.

Information

Type
Papers
Information
The British Journal of Psychiatry , Volume 147 , Issue 3 , September 1985 , pp. 306 - 309
Copyright
Copyright © 1985 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Beck, A. T., Ward, C. H., Mendelson, M, Mock, J. & Erbaugh, J. (1961) An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.CrossRefGoogle ScholarPubMed
Carney, M. W. P., Roth, M. & Garside, R. F. (1965) The diagnosis of depressive syndromes and the prediction of ECT response. British Journal of Psychiatry, 111, 659–674.CrossRefGoogle Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–61.CrossRefGoogle ScholarPubMed
LeFur, G. & Uzan, A. (1977) Effects of 4 (3-Indoiyl-alkyl) piperidine derivatives on uptake and release of noradrenaline, dopamine and 5-hydroxtryptamine. Biochemical Pharmacology, 26, 479–503.Google Scholar
Shopsin, B., Lefevre, C. & Maulet, C. (1983) Indalpine (LM 5008): An open study in depressed out-patients. Current Therapeutic Research, 34, 239–252.Google Scholar
Smith, A. H. W., Naylor, G. J. & Moody, J. P. (1978) Placebo controlled double-blind trial of mianserin hydrochloride. British Journal of Clinical Pharmacology, 5, 659–709.CrossRefGoogle ScholarPubMed
Spitzer, R. L., Endicott, J. & Robins, E. (1977) Research Diagnostic Criteria (RDC) for a Selected Group of Functional Disorders, 3rd ed. New York State Psychiatric Institute.Google Scholar
Wauters, A. (1983) Initial results of treatment with the new antidepressant Upstene. Acta Psychiatrica Belgica, 83, 69–74.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.